Mar 23 (Reuters) – Oryon Cell Therapies emerged from stealth on Monday with $21 million in new funding and early clinical data showing signs that its experimental therapy may help restore lost brain function in Parkinson’s patients.
The new tranche brings Oryon’s total funding to $42 million.
Here are some details:
(Reporting by Kamal Choudhury in Bengaluru; Editing by Mrigank Dhaniwala)
